Immunocore

IMCRNasdaq United Kingdom Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.635 B

$34.00 -1.45%

Close of 7 Aug 2026

Revenue

$400.0M

#2024 by revenue

Earnings

-$35.5M

Loss-making

Shares outstanding

51,498,617

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#36Taysha Gene TherapiesTSHA$1.89B
#37Recursion PharmaceuticalsRXRX$1.72B
#38ImmunocoreIMCR$1.64B
#39Maze TherapeuticsMAZE$1.59B
#40SL ScienceSLBT$1.50B

Where these numbers come from

Share counts and financials for Immunocore are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.